Abstract
Summary
Risperidone Microspheres for Injection is used to treat certain mental/mood disorders (such as schizophrenia, bipolar disorder). Risperidone belongs to a class of drugs known as atypical antipsychotics. It works by helping to restore the balance of certain natural substances in the brain.
The global Risperidone Microspheres for Injection market is projected to grow from US$ million in 2024 to US$ million by 2030, at a Compound Annual Growth Rate (CAGR) of %during the forecast period.
The US & Canada market for Risperidone Microspheres for Injection is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The China market for Risperidone Microspheres for Injection is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The Europe market for Risperidone Microspheres for Injection is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global key manufacturers of Risperidone Microspheres for Injection include Janssen Pharmaceuticals, Shandong Lvye Pharmaceutical, etc. In 2023, the global top five players had a share approximately % in terms of revenue.
Report Includes
This report presents an overview of global market for Risperidone Microspheres for Injection, sales, revenue and price. Analyses of the global market trends, with historic market revenue/sales data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.
This report researches the key producers of Risperidone Microspheres for Injection, also provides the sales of main regions and countries. Highlights of the upcoming market potential for Risperidone Microspheres for Injection, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Risperidone Microspheres for Injection sales, revenue, market share and industry ranking of main manufacturers, data from 2019 to 2024. Identification of the major stakeholders in the global Risperidone Microspheres for Injection market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Specification, and by Application, sales, revenue, and price, from 2019 to 2030. Evaluation and forecast the market size for Risperidone Microspheres for Injection sales, projected growth trends, production technology, application and end-user industry.
Descriptive company profiles of the major global players, including Janssen Pharmaceuticals, Shandong Lvye Pharmaceutical, etc.
Market Segmentation
By Company
Janssen Pharmaceuticals
Shandong Lvye Pharmaceutical
Segment by Specification
25mg
50mg
Others
Segment by Application
Schizophrenia
Other Mental Illnesses
Segment by region
US & Canada
U.S.
Canada
China
Asia (excluding China)
Japan
South Korea
China Taiwan
Southeast Asia
India
Australia
Europe
Germany
France
U.K.
Italy
Russia
Middle East, Africa, Latin America
Brazil
Mexico
Turkey
Israel
GCC Countries
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Specification, and by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Sales (consumption), revenue of Risperidone Microspheres for Injection in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 3: Detailed analysis of Risperidone Microspheres for Injection manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Specification, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: North America (US & Canada) by Specification, by Application and by country, sales, and revenue for each segment.
Chapter 7: Europe by Specification, by Application and by country, sales, and revenue for each segment.
Chapter 8: China by Specification, and by Application, sales, and revenue for each segment.
Chapter 9: Asia (excluding China) by Specification, by Application and by region, sales, and revenue for each segment.
Chapter 10: Middle East, Africa, and Latin America by Specification, by Application and by country, sales, and revenue for each segment.
Chapter 11: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Risperidone Microspheres for Injection sales, revenue, price, gross margin, and recent development, etc.
Chapter 12: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.
Chapter 13: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 14: The main points and conclusions of the report.
The global Risperidone Microspheres for Injection market is projected to grow from US$ million in 2024 to US$ million by 2030, at a Compound Annual Growth Rate (CAGR) of %during the forecast period.
The US & Canada market for Risperidone Microspheres for Injection is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The China market for Risperidone Microspheres for Injection is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The Europe market for Risperidone Microspheres for Injection is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global key manufacturers of Risperidone Microspheres for Injection include Janssen Pharmaceuticals, Shandong Lvye Pharmaceutical, etc. In 2023, the global top five players had a share approximately % in terms of revenue.
Report Includes
This report presents an overview of global market for Risperidone Microspheres for Injection, sales, revenue and price. Analyses of the global market trends, with historic market revenue/sales data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.
This report researches the key producers of Risperidone Microspheres for Injection, also provides the sales of main regions and countries. Highlights of the upcoming market potential for Risperidone Microspheres for Injection, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Risperidone Microspheres for Injection sales, revenue, market share and industry ranking of main manufacturers, data from 2019 to 2024. Identification of the major stakeholders in the global Risperidone Microspheres for Injection market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Specification, and by Application, sales, revenue, and price, from 2019 to 2030. Evaluation and forecast the market size for Risperidone Microspheres for Injection sales, projected growth trends, production technology, application and end-user industry.
Descriptive company profiles of the major global players, including Janssen Pharmaceuticals, Shandong Lvye Pharmaceutical, etc.
Market Segmentation
By Company
Janssen Pharmaceuticals
Shandong Lvye Pharmaceutical
Segment by Specification
25mg
50mg
Others
Segment by Application
Schizophrenia
Other Mental Illnesses
Segment by region
US & Canada
U.S.
Canada
China
Asia (excluding China)
Japan
South Korea
China Taiwan
Southeast Asia
India
Australia
Europe
Germany
France
U.K.
Italy
Russia
Middle East, Africa, Latin America
Brazil
Mexico
Turkey
Israel
GCC Countries
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Specification, and by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Sales (consumption), revenue of Risperidone Microspheres for Injection in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 3: Detailed analysis of Risperidone Microspheres for Injection manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Specification, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: North America (US & Canada) by Specification, by Application and by country, sales, and revenue for each segment.
Chapter 7: Europe by Specification, by Application and by country, sales, and revenue for each segment.
Chapter 8: China by Specification, and by Application, sales, and revenue for each segment.
Chapter 9: Asia (excluding China) by Specification, by Application and by region, sales, and revenue for each segment.
Chapter 10: Middle East, Africa, and Latin America by Specification, by Application and by country, sales, and revenue for each segment.
Chapter 11: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Risperidone Microspheres for Injection sales, revenue, price, gross margin, and recent development, etc.
Chapter 12: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.
Chapter 13: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 14: The main points and conclusions of the report.
Table of Contents
1 Study Coverage
1.1 Risperidone Microspheres for Injection Product Introduction
1.2 Market by Specification
1.2.1 Global Risperidone Microspheres for Injection Market Size Growth Rate by Specification, 2019 VS 2023 VS 2030
1.2.2 25mg
1.2.3 50mg
1.2.4 Others
1.3 Market by Application
1.3.1 Global Risperidone Microspheres for Injection Market Size Growth Rate by Application, 2019 VS 2023 VS 2030
1.3.2 Schizophrenia
1.3.3 Other Mental Illnesses
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Risperidone Microspheres for Injection Revenue Estimates and Forecasts 2019-2030
2.2 Global Risperidone Microspheres for Injection Revenue by Region
2.2.1 Global Risperidone Microspheres for Injection Revenue by Region: 2019 VS 2023 VS 2030
2.2.2 Global Risperidone Microspheres for Injection Revenue by Region (2019-2024)
2.2.3 Global Risperidone Microspheres for Injection Revenue by Region (2025-2030)
2.2.4 Global Risperidone Microspheres for Injection Revenue Market Share by Region (2019-2030)
2.3 Global Risperidone Microspheres for Injection Sales Estimates and Forecasts 2019-2030
2.4 Global Risperidone Microspheres for Injection Sales by Region
2.4.1 Global Risperidone Microspheres for Injection Sales by Region: 2019 VS 2023 VS 2030
2.4.2 Global Risperidone Microspheres for Injection Sales by Region (2019-2024)
2.4.3 Global Risperidone Microspheres for Injection Sales by Region (2025-2030)
2.4.4 Global Risperidone Microspheres for Injection Sales Market Share by Region (2019-2030)
2.5 US & Canada
2.6 Europe
2.7 China
2.8 Asia (excluding China)
2.9 Middle East, Africa and Latin America
3 Competition by Manufacturers
3.1 Global Risperidone Microspheres for Injection Sales by Manufacturers
3.1.1 Global Risperidone Microspheres for Injection Sales by Manufacturers (2019-2024)
3.1.2 Global Risperidone Microspheres for Injection Sales Market Share by Manufacturers (2019-2024)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Risperidone Microspheres for Injection in 2023
3.2 Global Risperidone Microspheres for Injection Revenue by Manufacturers
3.2.1 Global Risperidone Microspheres for Injection Revenue by Manufacturers (2019-2024)
3.2.2 Global Risperidone Microspheres for Injection Revenue Market Share by Manufacturers (2019-2024)
3.2.3 Global Top 10 and Top 5 Companies by Risperidone Microspheres for Injection Revenue in 2023
3.3 Global Key Players of Risperidone Microspheres for Injection, Industry Ranking, 2021 VS 2022
3.4 Global Risperidone Microspheres for Injection Sales Price by Manufacturers (2019-2024)
3.5 Analysis of Competitive Landscape
3.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.5.2 Global Risperidone Microspheres for Injection Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Key Manufacturers of Risperidone Microspheres for Injection, Manufacturing Base Distribution and Headquarters
3.7 Global Key Manufacturers of Risperidone Microspheres for Injection, Product Offered and Application
3.8 Global Key Manufacturers of Risperidone Microspheres for Injection, Date of Enter into This Industry
3.9 Mergers & Acquisitions, Expansion Plans
4 Market Size by Specification
4.1 Global Risperidone Microspheres for Injection Sales by Specification
4.1.1 Global Risperidone Microspheres for Injection Historical Sales by Specification (2019-2024)
4.1.2 Global Risperidone Microspheres for Injection Forecasted Sales by Specification (2025-2030)
4.1.3 Global Risperidone Microspheres for Injection Sales Market Share by Specification (2019-2030)
4.2 Global Risperidone Microspheres for Injection Revenue by Specification
4.2.1 Global Risperidone Microspheres for Injection Historical Revenue by Specification (2019-2024)
4.2.2 Global Risperidone Microspheres for Injection Forecasted Revenue by Specification (2025-2030)
4.2.3 Global Risperidone Microspheres for Injection Revenue Market Share by Specification (2019-2030)
4.3 Global Risperidone Microspheres for Injection Price by Specification
4.3.1 Global Risperidone Microspheres for Injection Price by Specification (2019-2024)
4.3.2 Global Risperidone Microspheres for Injection Price Forecast by Specification (2025-2030)
5 Market Size by Application
5.1 Global Risperidone Microspheres for Injection Sales by Application
5.1.1 Global Risperidone Microspheres for Injection Historical Sales by Application (2019-2024)
5.1.2 Global Risperidone Microspheres for Injection Forecasted Sales by Application (2025-2030)
5.1.3 Global Risperidone Microspheres for Injection Sales Market Share by Application (2019-2030)
5.2 Global Risperidone Microspheres for Injection Revenue by Application
5.2.1 Global Risperidone Microspheres for Injection Historical Revenue by Application (2019-2024)
5.2.2 Global Risperidone Microspheres for Injection Forecasted Revenue by Application (2025-2030)
5.2.3 Global Risperidone Microspheres for Injection Revenue Market Share by Application (2019-2030)
5.3 Global Risperidone Microspheres for Injection Price by Application
5.3.1 Global Risperidone Microspheres for Injection Price by Application (2019-2024)
5.3.2 Global Risperidone Microspheres for Injection Price Forecast by Application (2025-2030)
6 US & Canada
6.1 US & Canada Risperidone Microspheres for Injection Market Size by Specification
6.1.1 US & Canada Risperidone Microspheres for Injection Sales by Specification (2019-2030)
6.1.2 US & Canada Risperidone Microspheres for Injection Revenue by Specification (2019-2030)
6.2 US & Canada Risperidone Microspheres for Injection Market Size by Application
6.2.1 US & Canada Risperidone Microspheres for Injection Sales by Application (2019-2030)
6.2.2 US & Canada Risperidone Microspheres for Injection Revenue by Application (2019-2030)
6.3 US & Canada Risperidone Microspheres for Injection Market Size by Country
6.3.1 US & Canada Risperidone Microspheres for Injection Revenue by Country: 2019 VS 2023 VS 2030
6.3.2 US & Canada Risperidone Microspheres for Injection Revenue by Country (2019-2030)
6.3.3 US & Canada Risperidone Microspheres for Injection Sales by Country (2019-2030)
6.3.4 US
6.3.5 Canada
7 Europe
7.1 Europe Risperidone Microspheres for Injection Market Size by Specification
7.1.1 Europe Risperidone Microspheres for Injection Sales by Specification (2019-2030)
7.1.2 Europe Risperidone Microspheres for Injection Revenue by Specification (2019-2030)
7.2 Europe Risperidone Microspheres for Injection Market Size by Application
7.2.1 Europe Risperidone Microspheres for Injection Sales by Application (2019-2030)
7.2.2 Europe Risperidone Microspheres for Injection Revenue by Application (2019-2030)
7.3 Europe Risperidone Microspheres for Injection Market Size by Country
7.3.1 Europe Risperidone Microspheres for Injection Revenue by Country: 2019 VS 2023 VS 2030
7.3.2 Europe Risperidone Microspheres for Injection Revenue by Country (2019-2030)
7.3.3 Europe Risperidone Microspheres for Injection Sales by Country (2019-2030)
7.3.4 Germany
7.3.5 France
7.3.6 U.K.
7.3.7 Italy
7.3.8 Russia
8 China
8.1 China Risperidone Microspheres for Injection Market Size by Specification
8.1.1 China Risperidone Microspheres for Injection Sales by Specification (2019-2030)
8.1.2 China Risperidone Microspheres for Injection Revenue by Specification (2019-2030)
8.2 China Risperidone Microspheres for Injection Market Size by Application
8.2.1 China Risperidone Microspheres for Injection Sales by Application (2019-2030)
8.2.2 China Risperidone Microspheres for Injection Revenue by Application (2019-2030)
9 Asia (excluding China)
9.1 Asia Risperidone Microspheres for Injection Market Size by Specification
9.1.1 Asia Risperidone Microspheres for Injection Sales by Specification (2019-2030)
9.1.2 Asia Risperidone Microspheres for Injection Revenue by Specification (2019-2030)
9.2 Asia Risperidone Microspheres for Injection Market Size by Application
9.2.1 Asia Risperidone Microspheres for Injection Sales by Application (2019-2030)
9.2.2 Asia Risperidone Microspheres for Injection Revenue by Application (2019-2030)
9.3 Asia Risperidone Microspheres for Injection Market Size by Region
9.3.1 Asia Risperidone Microspheres for Injection Revenue by Region: 2019 VS 2023 VS 2030
9.3.2 Asia Risperidone Microspheres for Injection Revenue by Region (2019-2030)
9.3.3 Asia Risperidone Microspheres for Injection Sales by Region (2019-2030)
9.3.4 Japan
9.3.5 South Korea
9.3.6 China Taiwan
9.3.7 Southeast Asia
9.3.8 India
9.3.9 Australia
10 Middle East, Africa and Latin America
10.1 Middle East, Africa and Latin America Risperidone Microspheres for Injection Market Size by Specification
10.1.1 Middle East, Africa and Latin America Risperidone Microspheres for Injection Sales by Specification (2019-2030)
10.1.2 Middle East, Africa and Latin America Risperidone Microspheres for Injection Revenue by Specification (2019-2030)
10.2 Middle East, Africa and Latin America Risperidone Microspheres for Injection Market Size by Application
10.2.1 Middle East, Africa and Latin America Risperidone Microspheres for Injection Sales by Application (2019-2030)
10.2.2 Middle East, Africa and Latin America Risperidone Microspheres for Injection Revenue by Application (2019-2030)
10.3 Middle East, Africa and Latin America Risperidone Microspheres for Injection Market Size by Country
10.3.1 Middle East, Africa and Latin America Risperidone Microspheres for Injection Revenue by Country: 2019 VS 2023 VS 2030
10.3.2 Middle East, Africa and Latin America Risperidone Microspheres for Injection Revenue by Country (2019-2030)
10.3.3 Middle East, Africa and Latin America Risperidone Microspheres for Injection Sales by Country (2019-2030)
10.3.4 Brazil
10.3.5 Mexico
10.3.6 Turkey
10.3.7 Israel
10.3.8 GCC Countries
11 Corporate Profile
11.1 Janssen Pharmaceuticals
11.1.1 Janssen Pharmaceuticals Company Information
11.1.2 Janssen Pharmaceuticals Overview
11.1.3 Janssen Pharmaceuticals Risperidone Microspheres for Injection Sales, Price, Revenue and Gross Margin (2019-2024)
11.1.4 Janssen Pharmaceuticals Risperidone Microspheres for Injection Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Janssen Pharmaceuticals Recent Developments
11.2 Shandong Lvye Pharmaceutical
11.2.1 Shandong Lvye Pharmaceutical Company Information
11.2.2 Shandong Lvye Pharmaceutical Overview
11.2.3 Shandong Lvye Pharmaceutical Risperidone Microspheres for Injection Sales, Price, Revenue and Gross Margin (2019-2024)
11.2.4 Shandong Lvye Pharmaceutical Risperidone Microspheres for Injection Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Shandong Lvye Pharmaceutical Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Risperidone Microspheres for Injection Industry Chain Analysis
12.2 Risperidone Microspheres for Injection Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Risperidone Microspheres for Injection Production Mode & Process
12.4 Risperidone Microspheres for Injection Sales and Marketing
12.4.1 Risperidone Microspheres for Injection Sales Channels
12.4.2 Risperidone Microspheres for Injection Distributors
12.5 Risperidone Microspheres for Injection Customers
13 Risperidone Microspheres for Injection Market Dynamics
13.1 Risperidone Microspheres for Injection Industry Trends
13.2 Risperidone Microspheres for Injection Market Drivers
13.3 Risperidone Microspheres for Injection Market Challenges
13.4 Risperidone Microspheres for Injection Market Restraints
14 Key Findings in the Global Risperidone Microspheres for Injection Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
- 15.1.1.1 Research Programs/Design
- 15.1.1.2 Market Size Estimation
- 15.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
- 15.1.2.1 Secondary Sources
- 15.1.2.2 Primary Sources
15.2 Author Details
15.3 Disclaimer